Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People diagnosed with non-small cell lung cancer (a type of lung cancer), confirmed by a tissue or cell sample, where surgery to remove the cancer is not possible due to the cancer returning, spreading, or the person's overall health
- People who have already completed 2 to 4 rounds of first-line (initial) cancer treatment — such as chemotherapy, immunotherapy, or combinations of these — and whose cancer was assessed as stable (not growing or shrinking significantly) during that treatment
- People who have at least one tumour that can be measured on scans
- People who have not had radiotherapy to any tumour site in the 28 days before joining the trial
- People with a physical functioning score of 0–2 on a standard medical scale (meaning able to carry out at least some daily activities) (confirm with trial site)
- People whose life expectancy is estimated to be at least 3 months
- People who are willing to take part and have signed a consent form
Who may not be able to join:
- Women who are pregnant, breastfeeding, or planning to become pregnant within 6 months
- People with severe cancer spread to the brain or bones
- People with severe anaemia (very low red blood cell levels) or severe liver or kidney damage
- People whose pathology results or long-term follow-up records may not be available
- People whose relevant scan images and clinical records are not available
- People with serious illnesses that would make participation difficult, such as a recent major heart or stroke event, or other serious heart conditions
- People who have had surgery or any invasive procedure within 4 weeks before joining the trial
- People who are unable to tolerate standard second-line cancer treatment or other first-line therapies
- People with a known allergy to the study imaging agent (99mTc-H7ND) or any of its ingredients, or who have a history of severe allergic reactions
- People for whom the imaging procedures used in the trial are not medically suitable (confirm with trial site)
- People whom the trial investigator considers unsuitable for participation for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rui Gao, First Affiliated Hospital Xi'an Jiaotong University
Phone: 0086-13772488039
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
DCR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.